top of page
Rick Erickson
We derive our name from the latin word vincere meaning " to conquer"
OUR VISION
To address the unmet medical needs of our patients with paradigm-shifting therapeutics.
CLINICAL PROGRAM
VIP152 inhibits PTEFb phosphorylation of RNA polymerase II (RNAPII), thereby preventing transcription elongation and blocking expression of genes that drive cancer.
1/1
PIPELINE
bottom of page